Execution version


 


GLORI ENERGY INC.


 


SERIES C-2 PREFERRED STOCK AND WARRANT
PURCHASE AGREEMENT




March 13, 2014


 




    	 



    	 



    

 


TABLE OF CONTENTS


	 	 	 	Page
	 	 	 	 
	1.	Purchase and Sale of Series C-2 Preferred Stock and Warrants	1
	 	1.1	Sale and Issuance of Series C-2 Preferred Stock and Warrants; Closing Date	1
	 	1.2	Closing; Delivery	1
	 	1.3	Use of Proceeds	2
	 	1.4	Amendment to Merger Agreement	2
	 	1.5	Amendment to Merger Agreement	2
	 	1.6	Defined Terms Used in this Agreement	2
	2.	Representations and Warranties of the Company	5
	 	2.1	Organization, Good Standing, Corporate Power and Qualification	6
	 	2.2	Capitalization	6
	 	2.3	Subsidiaries	7
	 	2.4	Authorization	8
	 	2.5	Valid Issuance of Shares	8
	 	2.6	Governmental Consents and Filings	8
	 	2.7	Litigation	9
	 	2.8	Intellectual Property	9
	 	2.9	Compliance with Other Instruments	10
	 	2.10	Agreements; Actions	10
	 	2.11	Certain Transactions	11
	 	2.12	Rights of Registration and Voting Rights	11
	 	2.13	Absence of Liens	11
	 	2.14	Financial Statements	12
	 	2.15	Changes	12
	 	2.16	Employee Matters	12
	 	2.17	Tax Returns and Payments	14
	 	2.18	Insurance	14
	 	2.19	Confidential Information and Invention Assignment Agreements	14
	 	2.20	Permits	14
	 	2.21	Corporate Documents	14
	 	2.22	Real Property Holding Corporation	15
	 	2.23	Environmental and Safety Laws	15
	 	2.24	Qualified Small Business Stock	15
	 	2.25	Disclosure	16
	3.	Representations and Warranties of the Purchasers	16
	 	3.1	Authorization	16
	 	3.2	Purchase Entirely for Own Account	16
	 	3.3	Disclosure of Information	16
	 	3.4	Restricted Securities	17
	 	3.5	No Public Market	17
	 	3.6	Legends	17
	 	3.7	Accredited Investor	17
	 	3.8	Foreign Investor	17
	 	3.9	No General Solicitation	18
	 	3.10	Exculpation Among Purchasers	18


 




    	i



    	 



    

 


TABLE OF CONTENTS


 


	 	 	 	Page
	 	 	 	 
	 	3.11	Residence	18
	4.	Conditions to the Purchasers’ Obligations	18
	 	4.1	Representations and Warranties	18
	 	4.2	Performance	18
	 	4.3	Compliance Certificate	18
	 	4.4	Qualifications	18
	 	4.5	Board of Directors	18
	 	4.6	Indemnification Agreements	19
	 	4.7	Fifth Amended and Restated Investors’ Rights Agreement	19
	 	4.8	Fifth Amended and Restated Right of First Refusal and Co-Sale Agreement	19
	 	4.9	Fifth Amended and Restated Voting Agreement	19
	 	4.10	Restated Certificate	19
	 	4.11	Secretary’s Certificate	19
	 	4.12	Proceedings and Documents	19
	5.	Conditions TO the Company’s Obligations	19
	 	5.1	Representations and Warranties	19
	 	5.2	Performance	19
	 	5.3	Qualifications	19
	 	5.4	Fifth Amended and Restated Investors’ Rights Agreement	20
	 	5.5	Fifth Amended and Restated Right of First Refusal and Co-Sale Agreement	20
	 	5.6	Fifth Amended and Restated Voting Agreement	20
	6.	Miscellaneous	20
	 	6.1	Survival of Warranties	20
	 	6.2	Successors and Assigns	20
	 	6.3	Governing Law	20
	 	6.4	Counterparts; Facsimile	20
	 	6.5	Titles and Subtitles	20
	 	6.6	Notices	21
	 	6.7	No Finder’s Fees	21
	 	6.8	Attorney’s Fees	21
	 	6.9	Amendments and Waivers	21
	 	6.10	Severability	21
	 	6.11	Delays or Omissions	22
	 	6.12	Entire Agreement	22
	 	6.13	Dispute Resolution	22
	 	6.14	Indemnification	23
	 	6.15	No Commitment for Additional Financing	24
	 	6.16	Principal Business Operations	24
	 	 	 	 
	Exhibit A	Schedule of Purchasers	 
	Exhibit B	Form of Amended and Restated Certificate of Incorporation	 
	Exhibit C	Form of Warrant	 
	Exhibit D	Form of Warrant Termination Agreement 	 


 




    	ii



    	 



    

 


SERIES C-2 PREFERRED STOCK AND WARRANT
PURCHASE AGREEMENT


 


THIS SERIES C-2 PREFERRED
STOCK AND WARRANT PURCHASE AGREEMENT (the “Agreement”) is entered into as of March 13, 2014, by and among Glori
Energy Inc. (f/k/a Glori Oil Limited), a Delaware corporation (the “Company”), and the purchasers listed on
Exhibit A attached hereto (each a “Purchaser” and collectively, the “Purchasers”).


 


WHEREAS, the Company
desires to sell to the Purchasers, and the Purchasers desire to purchase from the Company, (a) shares of the Company's Series C-2
Preferred Stock, par value $0.0001 per share (the “Series C-2 Preferred Stock”), and (b) warrants (the “Warrants”)
to purchase shares of Series C-2 Preferred Stock, upon the terms and conditions hereinafter set forth.


 


NOW, THEREFORE, in
consideration of the foregoing, and of the mutual promises, representations, warranties, covenants and conditions set forth in
this Agreement, the parties hereto hereby agree as follows:


 


1.           Purchase
and Sale of Series C-2 Preferred Stock and Warrants.


 


1.1         Sale
and Issuance of Series C-2 Preferred Stock and Warrants; Closing Date.


 


(a)          The
Company shall adopt and file with the Secretary of State of the State of Delaware on or before the Closing (as defined below) the
Amended and Restated Certificate of Incorporation in the form of Exhibit B attached hereto (the “Restated Certificate”).


 


(b)          Subject
to the terms and conditions of this Agreement, the Purchasers agree to purchase at the Closing, and the Company agrees to sell
and issue to the Purchasers at the Closing, that number of shares of Series C-2 Preferred Stock set forth in the column designated
“Closing Shares” opposite such Purchaser’s name on Exhibit A, at a purchase price of $2.741
per share. The consideration for the purchased shares of Series C-2 Preferred Stock shall be paid in cash. The shares of Series
C-2 Preferred Stock, when issued to the Purchasers pursuant to this Agreement, shall be referred to in this Agreement as the “Shares.”


 


(c)          Subject
to the terms and conditions of this Agreement, the Company agrees to issue to each Purchaser at the Closing Warrants to purchase
that number of shares of Series C-2 Preferred Stock set forth opposite such Purchaser’s name on Exhibit A at an exercise
price of $2.741 per share of Series C-2 Preferred Stock. The Warrants shall be in the form of Exhibit C attached hereto.
The shares of Series C-2 Preferred Stock for which the Warrants are exercisable are herein referred to as “Warrant Shares”.


 


1.2         Closing;
Delivery.


 


(a)          The
purchase and sale of the Shares and the Warrants in the amounts as set forth on Exhibit A shall take place remotely via
the exchange of documents and signatures, at 10:00 a.m., Houston, Texas time, on the date hereof, or at such other time and place
as the Company and the Purchasers purchasing a majority of the Closing Shares shall mutually agree upon, orally or in writing (which
time and place are designated as the “Closing”).


 




    	 



    	 



    

 


(b)          At
the Closing, the Company shall deliver to each Purchaser (i) a certificate representing the Shares being purchased by such Purchaser
at the Closing against payment of the purchase price therefor by wire transfer to a bank account designated by the Company and
(ii) a Warrant exercisable for the number of Warrant Shares set forth opposite such Purchaser’s name on Exhibit A.


 


1.3         Use
of Proceeds. In accordance with the directions of the Board of Directors, as it shall be constituted in accordance with the
Fifth Amended and Restated Voting Agreement, the Company will use the proceeds from the sale of the Shares and Warrants for contribution
to a wholly owned subsidiary for its acquisition of oil and gas properties (consistent with the Company’s current business
model), working capital and general corporate purposes. The Company acknowledges that Texas ACP II, L.P. and Texas ACP Venture
Partners I, LLC have restrictions on the use of proceeds of their investments. The Company further acknowledges that no more than
50% of the proceeds received from Texas ACP II, L.P will be used for any repayment of indebtedness or any distributions to any
of the Stockholders and that none of the proceeds received from Texas ACP Venture Partners I, LLC will be used for any repayment
of indebtedness or any distributions to any of the Stockholders.


 


1.4         Amendment
to Merger Agreement. The Company shall take such necessary action, including causing the Merger Agreement to be amended, to
provide that, with respect to the shares of Glori Acquisition which the Purchasers shall receive as consideration for the Shares
upon consummation of the transactions contemplated by the Merger Agreement, (i) the Purchasers shall not be required to execute
and deliver Lock-Up Agreements and (ii) the Purchasers shall have registration rights similar to those of the investors participating
in the PIPE Investment.


 


1.5         Warrant
Termination Agreements. Each of the Purchasers hereby covenants and agrees to execute and deliver a Warrant Termination Agreement
substantially in the form of Exhibit D within 10 days after the Closing setting forth the amendment and termination of
the Warrants (and any other warrants for the purchase of Company Stock) held by such Purchaser in connection with the closing
of the Merger Agreement.


 


1.6         Defined
Terms Used in this Agreement. The following terms used in this Agreement shall be construed to have the meanings set forth
or referenced below.


 


“409A Plan”
shall have the meaning set forth in Section 2.2(f).


 


“AAA”
shall have the meaning set forth in Section 6.13.


 


“Affiliate”
means, with respect to any specified Person, any other Person who or which, directly or indirectly, controls, is controlled by,
or is under common control with such specified Person, including, without limitation, any partner, officer, director, member or
employee of such Person and any venture capital fund now or hereafter existing that is controlled by or under common control with
one or more general partners or managing members of, or shares the same management company with, such Person.


 




    	2



    	 



    

 


“Agreement”
shall have the meaning set forth in the preamble.


 


“Balance Sheet
Date” shall have the meaning set forth in Section 2.14.


 


“Board of
Directors” means the board of directors of the Company.


 


“Bylaws"
means the bylaws of the Company, as amended.


 


“Closing”
shall have the meaning set forth in Section 1.2(a).


 


“Closing Shares”
shall have the meaning set forth in Section 1.1(b).


 


“Code”
means the Internal Revenue Code of 1986, as amended.


 


“Common Stock”
shall have the meaning set forth in Section 2.2(a).


 


“Company”
shall have the meaning set forth in the preamble.


 


“Company Intellectual
Property” means all patents, patent applications, trademarks, trademark applications, service marks, tradenames, copyrights,
trade secrets, licenses, domain names, mask works, information and proprietary rights and processes as are necessary to the conduct
of the Company’s business as now conducted and as presently proposed to be conducted.


 


“Confidential
Information Agreements” shall have the meaning set forth in Section 2.19.


 


“Disclosure
Letter” shall have the meaning set forth in the first paragraph of Section 2.


 


“Environmental
Laws” shall have the meaning set forth in Section 2.23.


 


“ERISA”
shall have the meaning set forth in Section 2.16(g).


 


“Financial
Statements” shall have the meaning set forth in Section 2.14.


 


“Fifth
Amended and Restated Investors’ Rights Agreement” means that certain Fifth Amended and Restated Investors' Rights
Agreement, dated as of the date of the Closing, by and among the Company, The Energy and Resources Institute, the Purchasers and
certain other Stockholders.


 


“Fifth
Amended and Restated Right of First Refusal and Co-Sale Agreement” means that certain Fifth Amended and Restated Right
of First Refusal and Co-Sale Agreement, dated as of the date of the Closing, by and among the Company, the Purchasers, and certain
other Stockholders.


 




    	3



    	 



    

 


“Fifth
Amended and Restated Voting Agreement” means that certain Fifth Amended and Restated Voting Agreement, dated as of
the date of the Closing, by and among the Company, the Purchasers and certain other Stockholders.


 


“Glori Acquisition”
means Glori Acquisition Corp., a Delaware corporation.


 


“Hazardous
Substance” shall have the meaning set forth in Section 2.23.


 


“Indemnification
Agreement” means the indemnification agreements (if any) between the Company and any member of the Board of Directors
designated by any Purchaser entitled to designate a member of the Board of Directors pursuant to the Fifth Amended and Restated
Voting Agreement.


 


“Indemnified
Liabilities” shall have the meaning set forth in Section 6.14(a).


 


“Indemnitees”
shall have the meaning set forth in Section 6.14(a).


 


“Key Employee”
means any executive-level employee (including vice president-level positions) as well as any employee or consultant who either
alone or in concert with others develops, invents, programs or designs any Company Intellectual Property.


 


“Knowledge”,
including the phrase “to the Company’s knowledge”, shall mean the actual knowledge after reasonable investigation
of the following officers: Stuart M. Page and Victor Perez.


 


“Lock-Up Agreements”
means the Lock-Up Agreements to be executed and delivered by the holders of Company's capital stock as a condition to receipt of
shares of Glori Acquisition as consideration therefor upon the consummation of the transactions contemplated by the Merger Agreement.


 


“Material
Adverse Effect” means a material adverse effect on the business, assets (including intangible assets), liabilities, financial
condition, property, prospects or results of operations of the Company and its subsidiaries, taken as a whole.


 


"Merger Agreement"
means that certain Merger and Share Exchange Agreement, dated as of January 8, 2014, by and among Infinity Cross Border Acquisition
Corporation, Glori Acquisition, Glori Merger Subsidiary, Inc., the Company and Infinity-C.S.V.C. Management Ltd.


 


“PCB”
shall have the meaning set forth in Section 2.23.


 


“Person”
means any individual, corporation, partnership, trust, limited liability company, association or other entity.


 


“PIPE Investment”
means the private investment in public equity of at least $8,500,000 in Glori Acquisition at or prior to the closing of the Merger
Agreement.


 


“Preferred
Stock” shall have the meaning set forth in Section 2.2(b).


 




    	4



    	 



    

 


“Purchaser”
shall have the meaning set forth in the preamble.


 


“Restated
Certificate” shall have the meaning set forth in Section 1.1(a).


 


“SEC”
means the Securities and Exchange Commission.


 


“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


 


“Series A
Preferred Stock” means the Company's Series A Preferred Stock, par value $0.0001 per share.


 


“Series B
Preferred Stock” means the Company's Series B Preferred Stock, par value $0.0001 per share.


 


“Series C
Preferred Stock” means the Company's Series C Preferred Stock, par value $0.0001 per share.


 


“Series C-1
Preferred Stock” means the Company's Series C-1 Preferred Stock, par value $0.0001 per share.


 


“Series C-2
Preferred Stock” shall have the meaning set forth in the recitals.


 


“Shares”
shall have the meaning set forth in Section 1.1(b).


 


“Stock Plan”
shall have the meaning set forth in Section 2.2(c).


 


“Stockholders”
means, collectively, the holders of the Common Stock and the Preferred Stock.


 


“Transaction
Agreements” means this Agreement, the Fifth Amended and Restated Investors’ Rights Agreement, the Fifth Amended
and Restated Right of First Refusal and Co-Sale Agreement, the Fifth Amended and Restated Voting Agreement and the Indemnification
Agreements.


 


“Warrant Shares”
shall have the meaning set forth in Section 1.1(c).


 


“Warrants”
shall have the meaning set forth in the recitals.


 


2.          Representations
and Warranties of the Company. The Company hereby represents and warrants to each Purchaser that, except as set forth on the
disclosure letter delivered by the Company to the Purchasers at the Closing (the “Disclosure Letter”), which
exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are,
to the Company’s knowledge, true and complete as of the date of the Closing, except as otherwise indicated. The Disclosure
Letter shall be arranged in sections corresponding to the numbered and lettered sections and subsections contained in this Section
2 and Section 6.7, and the disclosures in any section or subsection of the Disclosure Letter shall qualify other sections
and subsections in this Section 2 or Section 6.7 only to the extent it is readily apparent from a reading of the
disclosure that such disclosure is applicable to such other sections and subsections. For purposes of these representations and
warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5 and 2.6), the term “the Company”
shall include any subsidiaries of the Company, unless otherwise noted herein.


 




    	5



    	 



    

 


2.1         Organization,
Good Standing, Corporate Power and Qualification. The Company is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as
presently conducted and as proposed to be conducted. The Company is duly qualified to transact business and is in good standing
in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.


 


2.2         Capitalization.
The authorized capital of the Company consists, immediately prior to the Closing, of:


 


(a)          100,000,000
shares of common stock, $0.0001 par value per share (the “Common Stock”), 3,295,771 shares of which are issued
and outstanding immediately prior to the Closing. All of the outstanding shares of Common Stock have been duly authorized, are
fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. The Company holds
no treasury stock and no shares of Preferred Stock in its treasury.


 


(b)          29,522,607
shares of preferred stock, $0.0001 par value per share (the “Preferred Stock”), (i) 521,852 of which have
been designated Series A Preferred Stock, 475,541 of which are issued and outstanding immediately prior to the Closing, (ii) 2,901,052
of which have been designated Series B Preferred Stock, 2,901,052 of which are issued and outstanding immediately prior to the
Closing, (iii) 13,780,033 of which have been designated Series C Preferred Stock, 7,296,607 of which are issued and outstanding
immediately prior to the Closing, (iv) 8,836,718 of which have been designated Series C-1 Preferred Stock, 4,462,968 of which
are issued and outstanding immediately prior to the Closing, and (v) 3,482,952 of which have been designated Series C-2 Preferred
Stock, none of which are issued and outstanding immediately prior to the Closing. The rights, privileges and preferences of the
Preferred Stock are as stated in the Restated Certificate and as provided by the general corporation law of the jurisdiction of
the Company’s incorporation.


 


(c)          The
Company has reserved 7,485,452 shares of Common Stock for issuance to officers, directors, employees and consultants of the Company
pursuant to its 2006 Stock Option and Grant Plan duly adopted by the Board of Directors and approved by the Stockholders (the “Stock
Plan”). Of the 7,485,452 shares of Common Stock reserved for issuance under the Stock Plan, (i) 6,734,322 of such shares
are reserved for issuance upon exercise of currently outstanding options and (ii) 751,130 shares remain available for future
stock options and other awards permitted under the Plan. The Company has furnished to the Purchasers complete and accurate copies
of the Stock Plan and forms of agreements used thereunder.


 




    	6



    	 



    

 


(d)          Section
2.2(d) of the Disclosure Letter sets forth the capitalization of the Company immediately following the Closing, including the
number of shares of the following: (i) issued and outstanding Common Stock, including, with respect to restricted Common Stock,
vesting schedule and repurchase price; (ii) issued stock options, including vesting schedule and exercise price; (iii) stock options
not yet issued but reserved for issuance; (iv) each series of Preferred Stock; and (v) warrants or stock purchase rights, including
the Warrants. Except for (X) the conversion privileges of the Shares and exercise rights with respect to the Warrant Shares to
be issued under this Agreement and the conversion privileges of the Series A Preferred Stock, the Series B Preferred Stock, the
Series C Preferred Stock, the Series C-1 Preferred Stock and the Series C-2 Preferred Stock, (Y) the rights provided in Section
4 of the Fifth Amended and Restated Investors’ Rights Agreement, and (Z) the securities and rights described in this Section
2.2 and in Section 2.2(d) of the Disclosure Letter, there are no outstanding options, warrants, rights (including conversion
or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire
from the Company any shares of Common Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series
C-1 Preferred Stock or Series C-2 Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock,
Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock or Series C-2 Preferred
Stock. Except as set forth in Section 2.2(d) of the Disclosure Letter, all outstanding shares of the Common Stock and all
shares of the Common Stock underlying outstanding options are subject to (I) a right of first refusal in favor of the Company upon
any proposed transfer (other than transfers for estate planning purposes); and (II) a lock-up or market standoff agreement of not
less than 180 days following the Company’s initial public offering pursuant to a registration statement filed with the SEC
under the Securities Act.


 


(e)          Except
as set forth in Section 2.2(e) of the Disclosure Letter, (i) none of the Company’s stock purchase agreements or stock
option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting
provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events; and (ii)
the Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment,
cancellation, replacement grant, repricing, or any other means. Except as set forth in the Restated Certificate, the Company has
no obligation (contingent or otherwise) to purchase or redeem any of its capital stock.


 


(f)          No
stock options, stock appreciation rights or other equity-based awards issued or granted by the Company are subject to the requirements
of Section 409A of the Code. Each “nonqualified deferred compensation plan” (as such term is defined under Section
409A(d)(1) of the Code and the guidance thereunder) under which the Company makes, is obligated to make or promises to make, payments
(each, a “409A Plan”) complies in all material respects, in both form and operation, with the requirements of
Section 409A of the Code and the guidance thereunder. No payment to be made under any 409A Plan is, or to the Company's knowledge
will be, subject to the penalties of Section 409A(a)(1) of the Code.


 


2.3           Subsidiaries.
Except as set forth in Section 2.3 of the Disclosure Letter, (i) the Company does not currently own or control, directly
or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association,
or other business entity; and (ii) the Company is not a participant in any joint venture, partnership or similar arrangement.


 




    	7



    	 



    

 


2.4           Authorization.
All corporate action required to be taken by the Board of Directors and the Stockholders in order to authorize the Company to enter
into the Transaction Agreements, and to issue the Shares at the Closing and the Common Stock issuable upon conversion of the Shares,
has been taken or will be taken prior to the Closing. All action on the part of the officers of the Company necessary for the execution
and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements
to be performed as of the Closing, and the issuance and delivery of the Shares and Warrants has been taken or will be taken prior
to the Closing. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding
obligations of the Company, enforceable against the Company in accordance with their respective terms except (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating
to or affecting the enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, or (iii) to the extent the indemnification provisions contained in
the Fifth Amended and Restated Investors’ Rights Agreement and each Indemnification Agreement may be limited by applicable
federal or state securities laws.


 


2.5           Valid
Issuance of Shares. The Shares and Warrants, when issued, sold and delivered in accordance with the terms and for the consideration
set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than
restrictions on transfer under the Transaction Agreements, the Restated Certificate, applicable state and federal securities laws
and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers
in Section 3 of this Agreement and subject to the filings described in subclause (b) of Section 2.6 below below,
the Shares and Warrants will be issued in compliance with all applicable federal and state securities laws. The Series C-2 Preferred
Stock issuable upon exercise of the Warrants and the Common Stock issuable upon conversion of the Shares and the Warrant Shares
have been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly
issued, fully paid, nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction
Agreements, the Restated Certificate, applicable federal and state securities laws and liens or encumbrances created by or imposed
by a Purchaser. Based in part upon the representations of the Purchasers in Section 3 of this Agreement, and subject to
Section 2.6 below, the Common Stock issuable upon conversion of the Shares and the Warrant Shares will be issued in
compliance with all applicable federal and state securities laws.


 


2.6           Governmental
Consents and Filings. Assuming the accuracy of the representations made by the Purchasers in Section 3 of this Agreement,
no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions
contemplated by this Agreement, except for (a) the filing of the Restated Certificate, which will have been filed as of the Closing,
and (b) filings pursuant to Regulation D of the Securities Act, and applicable state securities laws, which have been made
or will be made in a timely manner.


 




    	8



    	 



    

 


2.7           Litigation.
Except as set forth in Section 2.7 of the Disclosure Letter, there is no claim, action, suit, proceeding, arbitration, complaint,
charge or investigation pending or, to the Company’s knowledge, currently threatened (i) against the Company or any officer,
director or Key Employee of the Company arising out of their employment or Board of Directors relationship with the Company; (ii)
that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the
transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually
or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company’s knowledge, any of its officers,
directors or Key Employees is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree
of any court or government agency or instrumentality (in the case of officers, directors or Key Employees, such as would affect
the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate.
The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or
any basis therefor known to the Company) involving the prior employment of any of the Company’s employees, their services
provided in connection with the Company’s business, or any information or techniques allegedly proprietary to any of their
former employers, or their obligations under any agreements with prior employers.


 


2.8           Intellectual
Property. The Company owns or possesses sufficient legal rights to all Company Intellectual Property without, to the Company's
knowledge, any conflict with, or infringement of, the rights of others. To the Company’s knowledge, no product or service
marketed or sold (or proposed to be marketed or sold) by the Company violates or will violate any license or infringes or will
infringe any intellectual property rights of any other party. Other than as set forth in Section 2.8 of the Disclosure Letter,
other than with respect to commercially available software products under standard end-user object code license agreements, there
are no outstanding options, licenses, agreements, claims, encumbrances or shared ownership interests of any kind relating to the
Company Intellectual Property, nor is the Company bound by or a party to any options, licenses or agreements of any kind with respect
to the patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, proprietary rights and
processes of any other Person. The Company has not received any communications alleging that the Company has violated or, by conducting
its business, would violate any of the patents, trademarks, service marks, trade names, copyrights, trade secrets, mask works or
other proprietary rights or processes of any other Person. The Company has obtained and possesses valid licenses to use all of
the software programs present on the computers and other software-enabled electronic devices that it owns or leases or that it
has otherwise provided to its employees for their use in connection with the Company’s business. To the Company’s knowledge,
it will not be necessary to use any inventions of any of its employees or consultants (or Persons it currently intends to hire)
made prior to their employment by the Company. Each Company employee and consultant who has contributed to the Company Intellectual
Property has assigned to the Company all intellectual property rights he or she owns that are part of the Company Intellectual
Property. Section 2.8 of the Disclosure Letter lists all Company Intellectual Property that is registered or for which a
pending registration has been filed. The Company has not embedded any open source, copyleft or community source code in any of
its products generally available or in development, including but not limited to any libraries or code licensed under any General
Public License, Lesser General Public License or similar license arrangement. For purposes of this Section 2.8, the Company
shall be deemed to have knowledge of a patent right if the Company has actual knowledge of the patent right or would be found to
be on notice of such patent right as determined by reference to United States patent laws.


 




    	9



    	 



    

 


2.9           Compliance
with Other Instruments. The Company is not in violation or default (i) of any provisions of the Restated Certificate or the
Bylaws, (ii) of any instrument, judgment, order, writ or decree in which the Company is named or by which it is bound, (iii) under
any note, indenture or mortgage, or (iv) under any lease, agreement, contract or purchase order to which it is a party or by which
it is bound that is required to be listed on the Disclosure Letter, or of any provision of federal or state statute, rule or regulation
applicable to the Company, the violation of which would have a Material Adverse Effect. Other than as set forth in Section 2.9
of the Disclosure Letter, the execution, delivery and performance of the Transaction Agreements and the consummation of the transactions
contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or
without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ,
decree, contract or agreement or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets
of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.


 


2.10       Agreements;
Actions.


 


(a)          Except
for the Transaction Agreements and except as set forth in Section 2.10 of the Disclosure Letter, there are no agreements,
understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve
(i) obligations (contingent or otherwise) of, or payments to, the Company in excess of $100,000, (ii) the license of any patent,
copyright, trademark, trade secret or other proprietary right to or from the Company, (iii) the grant of rights to manufacture,
produce, assemble, license, market, or sell its products to any other Person that limit the Company’s exclusive right to
develop, manufacture, assemble, distribute, market or sell its products, or (iv) indemnification by the Company with respect to
infringements of proprietary rights.


 


(b)          Except
as set forth in Section 2.10 of the Disclosure Letter, the Company has not (i) declared or paid any dividends, or authorized
or made any distribution upon or with respect to any class or series of its capital stock, (ii) incurred any indebtedness for money
borrowed or incurred any other liabilities individually in excess of $100,000 or in excess of $1,000,000 in the aggregate, (iii)
made any loans or advances to any Person, other than ordinary advances for travel expenses, or (iv) sold, exchanged or otherwise
disposed of any of its assets or rights, other than the sale of its inventory in the ordinary course of business. For the purposes
of this Section 2.10(b) and Section 2.10(c) below, all indebtedness, liabilities, agreements, understandings, instruments,
contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated
with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such subsection.


 


(c)          The
Company is not a guarantor or indemnitor of any indebtedness of any other Person.


 




    	10



    	 



    

 


2.11       Certain
Transactions.


 


(a)          Except
as set forth in Section 2.11 of the Disclosure Letter, and other than (i) standard employee benefits generally made available
to all employees, (ii) standard director and officer indemnification agreements approved by the Board of Directors, and (iii) the
purchase of shares of the Company’s capital stock and the issuance of options to purchase shares of the Company’s Common
Stock, in each case, approved in the written minutes of the Board of Directors (previously provided to the Purchasers or their
counsel), there are no agreements, understandings or proposed transactions between the Company and any of its officers, directors,
consultants or Key Employees, or any Affiliate thereof.


 


(b)          Except
as set forth in Section 2.11 of the Disclosure Letter, the Company is not indebted, directly or indirectly, to any of its
directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other
than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses
and for other customary employee benefits made generally available to all employees. Except as set forth in Section 2.11
of the Disclosure Letter, none of the Company’s directors, officers or employees, or any members of their immediate families,
or any Affiliate of the foregoing (i) is, directly or indirectly, indebted to the Company or, (ii) to the Company’s knowledge,
has any direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the
Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers
or employees or stockholders of the Company may own stock in (but not exceeding two percent of the outstanding capital stock of)
publicly traded companies that may compete with the Company. None of the Company’s Key Employees or directors or any members
of their immediate families or any Affiliate of any of the foregoing are, directly or indirectly, interested in any contract with
the Company. None of the directors or officers of the Company, or any members of their immediate families, has any material commercial,
industrial, banking, consulting, legal, accounting, charitable or familial relationship with any of the Company’s customers,
suppliers, service providers, joint venture partners, licensees and competitors.


 


2.12       Rights
of Registration and Voting Rights. Except as provided in the Fifth Amended and Restated Investors’ Rights Agreement,
the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any
securities issuable upon exercise or conversion of its currently outstanding securities. To the Company’s knowledge, except
as contemplated in the Fifth Amended and Restated Voting Agreement, no Stockholder has entered into any agreement with respect
to the voting of capital shares of the Company.


 


2.13       Absence
of Liens. Except as set forth in Section 2.13 of the Disclosure Letter, the property and assets that the Company owns
are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment
of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not
materially impair the Company’s ownership or use of such property or assets. With respect to the property and assets it leases,
the Company is in compliance with such leases and, to its knowledge, holds a valid leasehold interest free of any liens, claims
or encumbrances other than those of the lessors of such property or assets.


 




    	11



    	 



    

 


2.14       Financial
Statements. The Company has delivered to each Purchaser its audited financial statements as of December 31, 2012 and for the
fiscal year ended December 31, 2012, and its unaudited financial statements (including balance sheet, income statement and statement
of cash flows) as of September 30, 2013 (the “Balance Sheet Date”) and for the period ended September 30, 2013
(collectively, the “Financial Statements”). Except as set forth in Section 2.14 of the Disclosure Letter,
the Financial Statements fairly present in all material respects the financial condition and operating results of the Company as
of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end
audit adjustments. Except as set forth in the Financial Statements, the Company has no material liabilities or obligations, contingent
or otherwise, other than liabilities incurred in the ordinary course of business subsequent to the Balance Sheet Date, obligations
under contracts and commitments incurred in the ordinary course of business and liabilities and obligations of a type or nature
not required under generally accepted accounting principles to be reflected in the Financial Statements, which, in all such cases,
individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain
a standard system of accounting established and administered in accordance with generally accepted accounting principles.


 


2.15       Changes.
Since the Balance Sheet Date, there have been no events or circumstances of any kind that have had or could reasonably be expected
to result in a Material Adverse Effect.


 


2.16       Employee
Matters.


 


(a)          As
of the date hereof, the Company employs 32 full-time employees, no part-time employees and no temporary employees and engages seven
consultants or independent contractors. Section 2.16(a) of the Disclosure Letter sets forth a detailed description of all
compensation, including salary, bonus, severance obligations and deferred compensation paid or payable for each officer, employee,
consultant and independent contractor of the Company who received compensation in excess of $50,000 for the fiscal year ended December
31, 2013 or is anticipated to receive compensation in excess of $50,000 for the fiscal year ending December 31, 2014.


 


(b)          To
the Company’s knowledge, none of its employees is obligated under any contract (including licenses, covenants or commitments
of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would
materially interfere with such employee’s ability to promote the interest of the Company or that would conflict with the
Company’s business. Neither the execution nor the delivery of the Transaction Agreements, nor the carrying on of the Company’s
business by the employees of the Company, nor the conduct of the Company’s business as now conducted and as presently proposed
to be conducted, will, to the Company’s knowledge, conflict with or result in a breach of the terms, conditions, or provisions
of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated.


 




    	12



    	 



    

 


(c)          As
of the date hereof, the Company is not delinquent in payments to any of its employees, consultants, or independent contractors
for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed on behalf of the Company
or amounts required to be reimbursed to such employees, consultants, or independent contractors. The Company has complied in all
material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment,
including those related to wages, hours, worker classification, and collective bargaining. The Company has withheld and paid to
the appropriate governmental entities or is holding for payment not yet due to such governmental entities all amounts required
to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties, or other sums for failure
to comply with any of the foregoing.


 


(d)          Except
as set forth in Section 2.16(d) of the Disclosure Letter, to the Company’s knowledge, no Key Employee intends to terminate
employment with the Company or is otherwise likely to become unavailable to continue as a Key Employee, nor does the Company have
a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable
at the will of the Company. Except as set forth in Section 2.16(d) of the Disclosure Letter or as required by law, upon
termination of the employment of any such employee, no severance or other payments will become due. Except as set forth in Section
2.16(d) of the Disclosure Letter, the Company has no policy, practice, plan, or program of paying severance pay or any form
of severance compensation in connection with the termination of employment services.


 


(e)          Except
as set forth in Section 2.16(e) of the Disclosure Letter, to the Company’s knowledge, the Company has not made any
representations regarding equity incentives to any officer, employee, director or consultant of the Company that are inconsistent
with the share amounts and terms set forth in the minutes of meetings of the Board of Directors.


 


(f)          Except
as set forth in Section 2.16(f) of the Disclosure Letter, each former Key Employee whose employment was terminated by the
Company has entered into an agreement with the Company providing for the full release of any claims against the Company or any
related party arising out of such employment.


 


(g)          Section
2.16(g) of the Disclosure Letter sets forth each employee benefit plan maintained, established or sponsored by the Company,
or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974,
as amended (“ERISA”). The Company has made all required contributions and has no liability to any such employee
benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied
in all material respects with all applicable laws for any such employee benefit plan.


 


(h)          The
Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express
or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the Company's knowledge,
has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute
involving the Company pending, or to the Company’s knowledge, threatened, which could have a Material Adverse Effect, nor
is the Company aware of any labor organization activity involving its employees.


 




    	13



    	 



    

 


(i)          To
the Company’s knowledge, none of the Key Employees or directors of the Company has been (A) subject to voluntary or involuntary
petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar
officer by a court for his business or property; (B) convicted in a criminal proceeding or named as a subject of a pending criminal
proceeding (excluding traffic violations and other minor offenses); (C) subject to any order, judgment, or decree (not subsequently
reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining him from engaging,
or otherwise imposing limits or conditions on his engagement in any securities, investment advisory, banking, insurance, or other
type of business or acting as an officer or director of a public company; or (D) found by a court of competent jurisdiction in
a civil action or by the SEC or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities,
or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.


 


2.17       Tax
Returns and Payments. There are no federal, state, county, local or foreign taxes due and payable by the Company which have
not been timely paid. There are no accrued and unpaid federal, state, country, local or foreign taxes of the Company which are
due, whether or not assessed or disputed. There have been no examinations or audits of any tax returns or reports by any applicable
federal, state, local or foreign governmental agency. The Company has duly and timely filed all federal, state, county, local and
foreign tax returns required to have been filed by it and there are in effect no waivers of applicable statutes of limitations
with respect to taxes for any year.


 


2.18       Insurance.
The Company has in full force and effect fire and casualty insurance policies with extended coverage, sufficient in amount (subject
to reasonable deductions) to allow it to replace any of its properties that might be damaged or destroyed.


 


2.19       Confidential
Information and Invention Assignment Agreements. Each current and former employee, consultant and officer of the Company has
executed an agreement with the Company regarding confidentiality and proprietary information substantially in the form or forms
delivered to the counsel for the Purchasers (the “Confidential Information Agreements”). No current or former
Key Employee has excluded works or inventions from his or her assignment of inventions pursuant to such Key Employee’s Confidential
Information Agreement. The Company is not aware that any of its Key Employees is in violation thereof.


 


2.20       Permits.
The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack
of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect
under any of such franchises, permits, licenses or other similar authority.


 


2.21       Corporate
Documents. The Restated Certificate and the Bylaws are in the forms provided to the Purchasers. The copy of the minute books
of the Company provided to the Purchasers contains minutes of all meetings of the Board of Directors and the Stockholders and all
actions by written consent without a meeting by the Board of Directors and the Stockholders since the date of incorporation and
accurately reflects in all material respects all actions by the Board of Directors (and any committee of the Board of Directors)
and the Stockholders with respect to all transactions referred to in such minutes.


 




    	14



    	 



    

 


2.22       Real
Property Holding Corporation. The Company is not now and has never been a “United States real property holding corporation”
as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service
all statements, if any, with its United States income tax returns which are required under such regulations.


 


2.23       Environmental
and Safety Laws. Except as could not reasonably be expected to have a Material Adverse Effect, (a) the Company is and has been
in compliance with all Environmental Laws; (b) there has been no release or, to the Company’s knowledge, threatened release
of any pollutant, contaminant or toxic or hazardous material, substance or waste, or petroleum or any fraction thereof, (each a
“Hazardous Substance”) on, upon, into or from any site currently or heretofore owned, leased or otherwise used
by the Company; (c) there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest
at any site that has been included in any published U.S. federal, state or local “superfund” site list or any other
similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d) there are
no underground storage tanks located on, no polychlorinated biphenyls (“PCB”) or PCB-containing equipment used
or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site
owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company
has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates
of need, permits, pending permit applications, correspondence, engineering studies, and environmental studies or assessments. For
purposes of this Section 2.23, “Environmental Laws” means any law, regulation, or other applicable requirement
relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety,
public health or the environment; or (c) the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous
Substances.


 


2.24       Qualified
Small Business Stock. As of and immediately following the Closing, (i) the Company will be an eligible corporation as defined
in Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B)
during the one-year period preceding the Closing, except for purchases that are disregarded for such purposes under Treasury Regulation
Section 1.1202-2 and (iii) the Company’s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between
its incorporation and through the Closing have exceeded $50 million, taking into account the assets of any corporations required
to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company
be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the
Company’s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination
shall have been given by the Company in a manner either grossly negligent or fraudulent.


 




    	15



    	 



    

 


2.25       Disclosure.
The Company has made available to the Purchasers all of the information reasonably available to the Company that the Purchasers
have requested for deciding whether to acquire the Shares. No representation or warranty of the Company contained in this Agreement,
as qualified by the Disclosure Letter, and no certificate furnished or to be furnished to the Purchasers at the Closing contains
any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained herein
or therein not misleading in light of the circumstances under which they were made. It is understood that this representation is
qualified by the fact that, except for the disclosures contained in this Agreement and in the Disclosure Letter, the Company has
not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written
disclosure of the types of information which may be furnished to purchasers of securities.


 


3.           Representations
and Warranties of the Purchasers. Each Purchaser hereby represents and warrants to the Company, severally and not jointly,
as follows:


 


3.1         Authorization.
The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which such Purchaser
is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser,
enforceable in accordance with their terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, and any other laws of general application affecting enforcement of creditors’ rights generally, and
as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (b)
to the extent the indemnification provisions contained in the Investors’ Rights Agreement may be limited by applicable federal
or state securities laws.


 


3.2         Purchase
Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to
the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Shares and Warrants
(including the Warrant Shares to be issued upon exercise of the Warrants) to be acquired by the Purchaser will be acquired for
investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution
of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing
the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract,
undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third
Person, with respect to any of the Shares or the Warrants (including the Warrant Shares to be issued upon exercise of the Warrants).
The Purchaser has not been formed for the specific purpose of acquiring the Shares or the Warrants (including the Warrant Shares
to be issued upon exercise of the Warrants).


 


3.3         Disclosure
of Information. The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs
and the terms and conditions of the offering of the Shares with the Company’s management and has had an opportunity to review
the Company’s facilities; provided, however, that the foregoing shall not limit or modify the representations and warranties
of the Company in Section 2 and Section 6.7 of this Agreement or the right of the Purchaser to rely thereon.


 




    	16



    	 



    

 


3.4         Restricted
Securities. The Purchaser understands that the Shares and the Warrant Shares have not been, and will not be, registered under
the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon,
among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations in
this Section 3. The Purchaser understands that the Shares and the Warrant Shares are “restricted securities”
under applicable U.S. federal and state securities laws and that, pursuant to such laws, the Purchaser must hold the Shares and
Warrant Shares indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such
registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register
or qualify the Shares, Warrant Shares, or the Common Stock into which they may be converted, for resale except as set forth in
the Fifth Amended and Restated Investors’ Rights Agreement. The Purchaser further acknowledges that if an exemption from
registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time
and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser’s
control, and which the Company is under no obligation and may not be able to satisfy.


 


3.5         No
Public Market. The Purchaser understands that no public market now exists for the Shares or the Warrant Shares, and that the
Company has made no assurances that a public market will ever exist for the Shares or the Warrant Shares.


 


3.6         Legends.
The Purchaser understands that the Shares, the Warrant Shares and any securities issued in respect of or exchange for the Shares
and Warrant Shares may bear one or all of the following legends:


 


(a)          “THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS
NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”;


 


(b)          any
legend set forth in, or required by, the other Transaction Agreements; and


 


(c)          any
legend required by the securities laws of any state to the extent such laws are applicable to the Shares or Warrant Shares represented
by the certificate so legended.


 


3.7         Accredited
Investor. The Purchaser is an accredited investor, as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act.


 


3.8         Foreign
Investor. If the Purchaser is not a United States person (as defined by Section 7701(a)(30) of the Code), such Purchaser hereby
represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation
to subscribe for the Shares and Warrants or any use of this Agreement, including (i) the legal requirements within its jurisdiction
for the purchase of the Shares and Warrants, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental
or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant
to the purchase, holding, redemption, sale, or transfer of the Shares and Warrants. Such Purchaser’s subscription and payment
for and continued beneficial ownership of the Shares and Warrants will not violate any applicable securities or other laws of the
Purchaser’s jurisdiction.


 




    	17



    	 



    

 


3.9         No
General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners
has either directly or indirectly, including through a broker or finder (a) engaged in any general solicitation, or (b) published
any advertisement in connection with the offer and sale of the Shares.


 


3.10       Exculpation
Among Purchasers. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers
and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that no Purchaser nor the respective
controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser
for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares or Warrants.


 


3.11       Residence.
If the Purchaser is a partnership, corporation, limited liability company or other entity, then the office address or addresses
of the Purchaser's principal place of business is identified under the Purchaser's name in Exhibit A.


 


4.           Conditions
to the Purchasers’ Obligations. The obligation of each Purchaser to purchase Shares and Warrants at the Closing is subject
to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived:


 


4.1         Representations
and Warranties. The representations and warranties of the Company contained in Section 2 and Section 6.7 shall
be true and correct in all material respects as of the Closing, except that any such representations and warranties shall be true
and correct in all respects where such representation and warranty is qualified with respect to materiality.


 


4.2         Performance.
The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by the Company on or before the Closing.


 


4.3         Compliance
Certificate. The Chief Executive Officer of the Company shall deliver to the Purchasers at the Closing a certificate certifying
that the conditions specified in Sections 4.1 and 4.2 have been fulfilled.


 


4.4         Qualifications.
All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any
state that are required in connection with the lawful issuance and sale of the Shares and Warrants pursuant to this Agreement shall
be obtained and effective as of the Closing.


 


4.5         Board
of Directors. As of the Closing, the authorized size of the Board of Directors shall be 10, and the Board of Directors shall
include each of Jonathan Schulhof, Michael Schulhof, Stuart Page, Matthew Gibbs, Ganesh Kishore, Mark Puckett, John Clarke, Larry
Aschebrook and Damon Rawie.


 




    	18



    	 



    

 


4.6         Indemnification
Agreements. The Company and each member of the Board of Directors designated by a Purchaser (other than any Purchaser relying
upon this condition to excuse such Purchaser’s performance hereunder) shall have executed and delivered the Indemnification
Agreements.


 


4.7         Fifth
Amended and Restated Investors’ Rights Agreement. The Company and each Purchaser and the other Stockholders named as
parties thereto shall have executed and delivered the Fifth Amended and Restated Investors’ Rights Agreement.


 


4.8         Fifth
Amended and Restated Right of First Refusal and Co-Sale Agreement. The Company, each Purchaser, and the other Stockholders
named as parties thereto shall have executed and delivered the Fifth Amended and Restated Right of First Refusal and Co-Sale Agreement.


 


4.9         Fifth
Amended and Restated Voting Agreement. The Company, each Purchaser and the other Stockholders named as parties thereto shall
have executed and delivered the Fifth Amended and Restated Voting Agreement.


 


4.10       Restated
Certificate. The Company shall have filed the Restated Certificate with the Secretary of State of the State of Delaware at
or prior to the Closing, and the Restated Certificate shall continue to be in full force and effect as of the Closing.


 


4.11       Secretary’s
Certificate. The secretary of the Company shall have delivered to the Purchasers at the Closing a certificate certifying (i)
the Bylaws, (ii) resolutions of the Board of Directors approving the Transaction Agreements and the transactions contemplated under
the Transaction Agreements, and (iii) resolutions of the Stockholders approving the Restated Certificate.


 


4.12       Proceedings
and Documents. All corporate and other proceedings in connection with the transactions contemplated at the Closing and all
documents incident thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its
counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested.


 


5.          Conditions
to the Company’s Obligations. The obligation of the Company to sell the Shares and the Warrants to the Purchasers at
the Closing is subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived:


 


5.1         Representations
and Warranties. The representations and warranties of each Purchaser contained in Section 3 and Section 6.7 shall
be true and correct in all material respects as of the Closing.


 


5.2         Performance.
The Purchasers shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by them on or before the Closing.


 


5.3         Qualifications.
All authorizations, approvals and permits, if any, of any governmental authority or regulatory body of the United States or of
any state that are required in connection with the lawful issuance and sale of the Shares and Warrants pursuant to this Agreement
shall have been obtained and shall be effective as of the Closing.


 




    	19



    	 



    

 


5.4         Fifth
Amended and Restated Investors’ Rights Agreement. Each Purchaser and the other Stockholders named as parties thereto
shall have executed and delivered the Fifth Amended and Restated Investors’ Rights Agreement.


 


5.5         Fifth
Amended and Restated Right of First Refusal and Co-Sale Agreement. Each Purchaser and the other Stockholders named as parties
thereto shall have executed and delivered the Fifth Amended and Restated Right of First Refusal and Co-Sale Agreement.


 


5.6         Fifth
Amended and Restated Voting Agreement. Each Purchaser and the other Stockholders named as parties thereto shall have executed
and delivered the Fifth Amended and Restated Voting Agreement.


 


6.          Miscellaneous.


 


6.1         Survival
of Warranties. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers
contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and
shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers
or the Company.


 


6.2         Successors
and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties hereto. Nothing in this Agreement, express or implied, is intended to confer upon any Person other than
the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason
of this Agreement, except as expressly provided in this Agreement.


 


6.3         Governing
Law. This Agreement and any controversy arising out of or relating to this Agreement shall be governed by and construed in
accordance with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other
matters, shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflict
of law principles that would result in the application of any law other than the laws of the State of New York.


 


6.4         Counterparts;
Facsimile. This Agreement, any Transaction Agreement and any other document prepared in connection with the transactions contemplated
hereby or thereby may be executed and delivered by facsimile signature or by email in portable document format and in two or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.


 


6.5         Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.


 




    	20



    	 



    

 


6.6         Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent
during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one business day after deposit with
a nationally recognized overnight courier, specifying next business day delivery, with written verification of receipt. All communications
shall be sent to the parties hereto at their respective addresses as set forth on the signature page to this Agreement or Exhibit
A, as applicable, or to such e-mail address, facsimile number or address as subsequently modified by written notice given in
accordance with this Section 6.6. If notice is given to the Company, a copy shall also be sent to Norton Rose Fulbright,
Fulbright Tower, 1301 McKinney, Suite 5100, Houston, Texas, 77010-3095, Attn: Charles D. Powell.


 


6.7         No
Finder’s Fees. Except as set forth in Section 6.7 of the Disclosure Letter, each party hereto represents that
it neither is, nor will be, obligated for any finder’s fee or commission in connection with this transaction. Each Purchaser
agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s
or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted
liability) for which any Purchaser or any of its officers, employees, or representatives is responsible. The Company agrees to
indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder’s
or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted
liability) for which the Company or any of its officers, employees or representatives is responsible.


 


6.8         Attorney’s
Fees. If any action at law or in equity (including arbitration) is necessary to enforce or interpret the terms of any of the
Transaction Agreements, the prevailing party shall be entitled to reasonable attorney’s fees, costs and necessary disbursements
in addition to any other relief to which such party may be entitled.


 


6.9         Amendments
and Waivers. Any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and
the holders of at least 662/3% of the voting power of the then outstanding Series C-2 Preferred Stock. Any
amendment or waiver effected in accordance with this Section 6.9 shall be binding upon each of the Purchasers and each transferee
of the Shares, the Warrants or the Warrant Shares (or the Common Stock issuable upon conversion of any of the foregoing), each
future holder of any such securities, and the Company.


 


6.10       Severability.
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision
hereof.


 




    	21



    	 



    

 


6.11       Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party hereto under this Agreement,
upon any breach or default of any other party hereto under this Agreement, shall impair any such right, power or remedy of such
non-breaching or non-defaulting party hereto nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of
any kind or character on the part of any party hereto of any breach or default under this Agreement, or any waiver on the part
of any party hereto of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, whether under this Agreement, by law or otherwise, afforded to any party
hereto, shall be cumulative and not alternative.


 


6.12       Entire
Agreement. This Agreement (including the Exhibits hereto and the Disclosure Letter), the Restated Certificate and the other
Transaction Agreements constitute the full and entire understanding and agreement between the parties hereto with respect to the
subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties
hereto are expressly canceled.


 


6.13       Dispute
Resolution. Any unresolved controversy or claim arising out of or relating to this Agreement, except (i) as otherwise provided
in this Agreement, or (ii) for any such controversies or claims arising out of the intellectual property rights of a party hereto
for which a provisional remedy or equitable relief is sought, shall be submitted to arbitration by one arbitrator mutually agreed
upon by the parties to such arbitration, and if no agreement can be reached within 30 days, then by one arbitrator having reasonable
experience in corporate finance transactions of the type provided for in this Agreement and who is chosen by the American Arbitration
Association (the “AAA”). The arbitration shall take place in the city of Houston, Texas (unless otherwise agreed
to in writing by the parties to the arbitration), in accordance with the then current Commercial Arbitration Rules of the AAA (which
rules are hereby incorporated as an integral part of this Agreement), and judgment upon any award rendered in such arbitration
will be binding and may be entered in any court having jurisdiction thereof. There shall be limited discovery prior to the arbitration
hearing as follows: (X) exchange of witness lists and copies of documentary evidence and documents relating to or arising out of
the issues to be arbitrated, (Y) depositions of all party witnesses and (Z) such other depositions as may be allowed by the arbitrator
upon a showing of good cause. Depositions shall be conducted in accordance with the New York Code of Civil Procedure. The arbitrator
shall be required to provide in writing to the parties to the arbitration the basis for the award or order of such arbitrator,
and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. The
party prevailing in the arbitration, as determined by the arbitrator, shall be entitled to recover its reasonable attorneys' fees,
costs, and necessary disbursements in addition to any other relief to which such party may be entitled.


 




    	22



    	 



    

 


6.14       Indemnification.


 


(a)          In
consideration of each Purchaser’s execution and delivery of this Agreement and fulfillment of its, his or her obligations
hereunder, and in addition to all of the Company’s other obligations under this Agreement, the Company shall defend, protect,
indemnify and hold harmless each Purchaser and each Purchaser’s Affiliates, officers, directors, employees and agents (including,
without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages,
and expenses (including, without limitation, costs of suit and reasonable attorneys’ fees and expenses) in connection therewith
(irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought) (the “Indemnified
Liabilities”), incurred by such Indemnitee as a result of, or arising out of, or relating to any breach of any representation,
warranty, covenant or agreement made by the Company herein. Notwithstanding the foregoing, the Company shall have no obligation
under this Section 6.14(a) to defend, protect, indemnify or hold harmless any Indemnitee with respect to any Indemnified
Liability to the extent resulting from or arising out of the negligence or willful misconduct of any Indemnitee. Subject to Section
6.14(b), the Company shall reimburse the Indemnitees for the Indemnified Liabilities as such Indemnified Liabilities are incurred.
To the extent the Company's undertakings under this Section 6.14(a) may be unenforceable for any reason, the Company shall
make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under
applicable law.


 


(b)          In
connection with the obligation of the Company to indemnify for expenses as set forth in Section 6.14(a) above, the Company
shall, upon presentation of appropriate invoices containing reasonable detail, reimburse each Indemnitee for any such Indemnified
Liability incurred by such Indemnitee as the same may be incurred by such Indemnitee; provided, however, that if any such Indemnified
Liabilities are incurred pursuant to a cause of action initiated by an Indemnitee against the Company, between the Company and
such Indemnitee, such Indemnified Liabilities shall be reimbursed by the Company upon the final determination pursuant to Section
6.13, or otherwise by a court of competent jurisdiction, that the Company has breached a representation, warranty, covenant
or agreement made by the Company herein.


 


(c)          The
obligations of the Company in respect of a claim for indemnification or any other claim related to this Agreement shall not include
any consequential, punitive, special or exemplary damages, including any damages on account of lost profits or opportunities, business
interruption or diminution in value. Notwithstanding anything to the contrary contained in this Agreement, the Company’s
total liability to any Indemnitee under this Section 6.14, or otherwise out of any transaction contemplated herein, shall
not exceed the purchase price actually paid to the Company by such Indemnitee for the Shares and Warrants pursuant to this Agreement.


 


(d)          Other
than as set forth in this Section 6.14, or with respect to any claim for fraud in the negotiation or execution of this Agreement,
indemnification pursuant to this Section 6.14 shall be the sole and exclusive remedy for the parties hereto with respect
to matters arising under this Agreement of any kind or nature, including for any misrepresentation or breach of any warranty, covenant,
or other provision contained in this Agreement, and each party hereto hereby waives and releases any other rights, remedies, causes
of action, or claims that such party may have or that may arise against any other parties hereto with respect thereto.


 




    	23



    	 



    

 


6.15        No
Commitment for Additional Financing. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking,
commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than
the purchase of the Shares and Warrants as set forth herein and subject to the conditions set forth herein. In addition, the Company
acknowledges and agrees that (i) no statements, whether written or oral, made by any Purchaser or its representatives on or after
the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any
financing or investment, (ii) the Company shall not rely on any such statement by any Purchaser or its representatives and (iii)
an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created
by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment
and stating that such Persons intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right,
in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company,
and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.


 


6.16        Principal
Business Operations.  The Company will remain headquartered in the State of Texas and maintain business operations in
the State of Texas and will not move its principal business operations from the State of Texas for a period of at least 90 days
after the date of the Closing.


 


[Remainder of page intentionally left
blank. Signature Page Follows.]


 




    	24



    	 



    

 


IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first written above.


 


	 	GLORI ENERGY INC.
	 	 	 
	 	By:	/s/ Stuart
    Page
	 	 	Stuart Page
	 	 	President and Chief Executive Officer


 


	 	Address: 	4315 South Drive
	 	 	Houston, TX  77053


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	 	Texas ACP II, L.P.
	 	 
	 	By: ADVTG GP II, L.L.C., its General Partner
	 	 
	 	By:	/s/ Damon Rawie
	 	Name:	Damon Rawie
	 	Title:	Vice President
	 	 	 
	 	Texas ACP Venture Partners I, LLC
	 	 	 
	 	By:	/s/ Damon Rawie
	 	Name:	Damon Rawie
	 	Title:	Vice President 


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	 	OXFORD BIOSCIENCE PARTNERS V L.P.
	 	By:  OBP Management V L.P.
	 	 	 
	 	By: 	/s/ Matthew A. Gibbs
	 	 	Matthew A. Gibbs – General Partner
	 	 	 
	 	mRNA FUND V L.P.
	 	By:  OBP Management V L.P.
	 	 
	 	By: 	/s/ Matthew A. Gibbs
	 	 	Matthew A. Gibbs – General Partner


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	 	MALAYSIAN LIFE SCIENCES CAPITAL FUND LTD.
	 	 
	 	By:	Malaysian Life Sciences Capital Fund Management Company Ltd, its Manager
	 	 	 
	 	By:	/s/ Roger Wyse
	 	Name:	Roger Wyse
	 	Title:	Co-Chairman


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


		ENERGY TECHNOLOGY VENTURES, LLC
	 	 
	 	By:	/s/ Steven Taub
	 	Name:	Steven Taub
	 	Title:	Authorized Representative


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	 	GTI VENTURES, LLC
	 	 	 
	 	By:	/s/ Jonathan Schulhof
	 	Name:	Jonathan Schulhof
	 	Title:	President


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	 	KPCB HOLDINGS, INC.
	 	 
	 	By:	/s/ Paul M. Vronsky
	 	Name:	Paul M. Vronsky
	 	Title:	General Counsel 


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	 	GENTRY TECHNOLOGY FUND I, LLC
	 	 	 
	 	By:	/s/ Larry Aschebrook
	 	Name:	Larry Aschebrook
	 	Title:	Manager 


 


Signature Page to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


EXHIBIT A


 


SCHEDULE OF PURCHASERS


 


	Investor	 	Purchase Price
 for Closing	 	 	Total Closing
 Shares	 	 	Total
 Warrants	 
	Texas ACP II, L.P.	 	 	 	 	 	 	 	 	 	 	 	 
	5000 Plaza on the Lake	 	 	 	 	 	 	 	 	 	 	 	 
	Suite 195	 	 	 	 	 	 	 	 	 	 	 	 
	Austin, Texas 78746	 	 	 	 	 	 	 	 	 	 	 	 
	Attention:  Damon Rawie	 	$	1,250,000.16	 	 	 	456,038	 	 	 	406,250	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	With a copy to:	 	 	 	 	 	 	 	 	 	 	 	 
	Kelley Drye &Warren LLP	 	 	 	 	 	 	 	 	 	 	 	 
	Attn:  Thomas Ferguson	 	 	 	 	 	 	 	 	 	 	 	 
	333 W. Wacker Dr., Suite 2600	 	 	 	 	 	 	 	 	 	 	 	 
	Chicago, IL 60606	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Texas ACP Venture Partners I, LLC	 	 	 	 	 	 	 	 	 	 	 	 
	5000 Plaza on the Lake	 	 	 	 	 	 	 	 	 	 	 	 
	Suite 195	 	 	 	 	 	 	 	 	 	 	 	 
	Austin, Texas 78746	 	 	 	 	 	 	 	 	 	 	 	 
	Attention:  Damon Rawie	 	$	499,999.52	 	 	 	182,415	 	 	 	162,500	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	With a copy to:	 	 	 	 	 	 	 	 	 	 	 	 
	Kelley Drye &Warren LLP	 	 	 	 	 	 	 	 	 	 	 	 
	Attn:  Thomas Ferguson	 	 	 	 	 	 	 	 	 	 	 	 
	333 W. Wacker Dr., Suite 2600	 	 	 	 	 	 	 	 	 	 	 	 
	Chicago, IL 60606	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Oxford Bioscience Partners V L.P.	 	 	 	 	 	 	 	 	 	 	 	 
	535 Boylston Street, Suite 402 Boston, MA 02116	 	$	977,961.39	 	 	 	356,790	 	 	 	317,837	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	mRNA Fund V L.P.	 	 	 	 	 	 	 	 	 	 	 	 
	535 Boylston Street, Suite 402	 	$	22,037.64	 	 	 	8,040	 	 	 	7,162	 
	Boston, MA 02116	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Malaysian Life Sciences Capital	 	 	 	 	 	 	 	 	 	 	 	 
	Fund Ltd.	 	 	 	 	 	 	 	 	 	 	 	 
	c/o Burrill & Company 	 	 	 	 	 	 	 	 	 	 	 	 
	One Embarcadero Center, Suite 2700	 	$	499,999.52	 	 	 	182,415	 	 	 	162,500	 
	San Francisco, CA 94111	 	 	 	 	 	 	 	 	 	 	 	 
	Attn:  Greg Young	 	 	 	 	 	 	 	 	 	 	 	 



 


Exhibit A to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


	Investor	 	Purchase Price
 for Closing	 	 	Total Closing
 Shares	 	 	Total
 Warrants	 
	Energy Technology Ventures, LLC	 	 	 	 	 	 	 	 	 	 	 	 
	c/o GE Ventures, LLC	 	 	 	 	 	 	 	 	 	 	 	 
	2882 Sand Hill Road	 	 	 	 	 	 	 	 	 	 	 	 
	Menlo Park, CA 94025	 	 	 	 	 	 	 	 	 	 	 	 
	Attn: General Counsel	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	With a copy to:	 	$	499,999.52	 	 	 	182,415	 	 	 	162,500	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Lisa R. Blanco	 	 	 	 	 	 	 	 	 	 	 	 
	General Counsel & Chief Compliance Officer	 	 	 	 	 	 	 	 	 	 	 	 
	Energy Technology Ventures, LLC	 	 	 	 	 	 	 	 	 	 	 	 
	Email: lisablanco@me.com	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	GTI Ventures, LLC	 	 	 	 	 	 	 	 	 	 	 	 
	150 East 58th Street	 	 	 	 	 	 	 	 	 	 	 	 
	24th Floor	 	$	125,000.57	 	 	 	45,604	 	 	 	40,625	 
	New York, NY 10155	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	KPCB Holdings, Inc.	 	 	 	 	 	 	 	 	 	 	 	 
	2750 Sand Hill Road	 	$	50,001.32	 	 	 	18,242	 	 	 	16,250	 
	Menlo Park, CA 94025	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Gentry Technology Fund I, LLC	 	 	 	 	 	 	 	 	 	 	 	 
	c/o Gentry Financial Partners	 	 	 	 	 	 	 	 	 	 	 	 
	205 N. Michigan Ave., Suite 3770	 	 	 	 	 	 	 	 	 	 	 	 
	Chicago, IL 60601	 	 	 	 	 	 	 	 	 	 	 	 
	Attn: Thomas B. Raterman	 	$	1,123,999.13	 	 	 	410,069	 	 	 	365,300	 
	With a copy to:	 	 	 	 	 	 	 	 	 	 	 	 
	Kelley Drye &Warren LLP	 	 	 	 	 	 	 	 	 	 	 	 
	Attn:  Thomas Ferguson	 	 	 	 	 	 	 	 	 	 	 	 
	333 W. Wacker Dr., Suite 2600	 	 	 	 	 	 	 	 	 	 	 	 
	Chicago, IL 60606	 	 	 	 	 	 	 	 	 	 	 	 
	Total:	 	$	5,048,998.77	 	 	 	1,842,028	 	 	 	1,640,924	 



 


Exhibit A to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


EXHIBIT B


 


FORM OF AMENDED AND RESTATED CERTIFICATE
OF INCORPORATION


 


[See attached.]


 


Exhibit B to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


EXHIBIT C


 


FORM OF WARRANT


 


[See attached.]


 


Exhibit C to Series C-2 Preferred
Stock and Warrant Purchase Agreement


 




    	 



    	 



    

 


EXHIBIT D


 


FORM OF WARRANT TERMINATION AGREEMENT


 


[See attached.]


 


Exhibit D to Series C-2 Preferred
Stock and Warrant Purchase Agreement